Stocks
Mirati Therapeutics, Inc.MRTX
NASDAQHealthcareBiotechnology$58.70-0.17%
Focused on oncology drug development, the company develops targeted cancer therapies aimed at genetically defined tumors, with a particular emphasis on KRAS-driven cancers. Its lead asset, the KRAS G12C inhibitor adagrasib, has been a key driver of investor attention as the firm works through regula...
Market Cap: $4.1B52W Range: $27.30 – $64.41
This page tracks all publicly disclosed congressional trades in Mirati Therapeutics, Inc. (MRTX), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 1 purchase and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-04-10 | Daniel Goldman | sell | $1K – $15K |
| 2023-03-06 | Daniel Goldman | buy | $1K – $15K |